Biocon, Mylan drug discovery programme makes progress

Last Updated: Thursday, May 7, 2015, 14:01

Biocon shares were trading at Rs 425.90 apiece, up 0.16%, on the BSE.

Sun Pharma, Israel university ink pact to develop anti-cancer drugs

Last Updated: Wednesday, April 15, 2015, 19:05

Sun Pharmaceutical Industries has inked a pact with Israel's Technion university to develop anti-cancer drugs.

Stada agrees oncology deal with Indian Hetero Drugs

Last Updated: Thursday, March 26, 2015, 15:57

German generic drugmaker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.

GSK Pharma to transfer cancer drug portfolio to Novartis arm

Last Updated: Thursday, February 12, 2015, 21:59

GlaxoSmithKline Pharmaceuticals board on Thursday approved transfer of its cancer drugs portfolio to an arm of Novartis in India in return for acquiring vaccines portfolio as part of a global deal between the two-multinational pharma giants struck last year.

Supreme Court rejects Novartis cancer drug Glivec patent plea

Last Updated: Monday, April 1, 2013, 09:27

Glivec, used in treating chronic myeloid leukemia and some other cancers, costs a patient about Rs 1.2 lakh/month, much higher than Rs 8,000 which is the price of the generic drug.

Cancer drug ruling: It is triumph of human values, says Natco Director

Last Updated: Friday, March 8, 2013, 19:16

The IPAB ruling in favour of the Natco Pharma against Bayer has reignited the debate over innovation versus access in the health sector.

Cipla slashes cancer drug prices by 64%

Last Updated: Thursday, November 8, 2012, 16:13

Drug major Cipla on Thursday slashed prices of its three generic cancer drugs -- Erlocip, Docetax and Capegard -- by up to 64 percent.

Sun Pharma awaits USFDA approval for cancer drug Lipodox

Last Updated: Sunday, October 28, 2012, 10:52

After gaining market access under a contingency plan by the USFDA, drug major Sun Pharmaceutical Industries is awaiting approval from the health regulator for its cancer drug Lipodox.

Lupin identifies cancer drugs as focus area in Japan

Last Updated: Sunday, October 14, 2012, 11:57

Lupin has presence in both oral and injectable products development and manufacturing infrastructure in Japan.

Cipla slashes cancer drug prices by up to 76%

Last Updated: Thursday, May 3, 2012, 20:37

Drug major Cipla on Thursday slashed the prices by up to 76 percent of its generic drugs, used in treating cancers of brain, lung and kidney.

Insight: Chasing cheaper cancer drugs

Last Updated: Monday, April 2, 2012, 09:24

In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer drug research for their work in discovering a stream of new medicines.

Roche to slash prices of expensive cancer drugs in India

Last Updated: Friday, March 23, 2012, 17:40

Global pharma major Roche is all set to slash the price of two expensive cancer drugs in India, as part of efforts to strengthen its position amid rising competition from generic drug makers, says a media report.